LCN2 and stroke disorder: Recent research suggests stroke-triggered reactive astrocytes overexpress lipocalin 2 (LCN2), binding to low-density lipoprotein receptor-related protein 1 (LRP1), activating phagocytosis and inducing astrocytes to phagocytose myelin fragments, causing demyelinating lesions (Wan et al., 2022).